MX2022001601A - Composicion farmaceutica que contiene un agente antifungico como ingrediente activo. - Google Patents

Composicion farmaceutica que contiene un agente antifungico como ingrediente activo.

Info

Publication number
MX2022001601A
MX2022001601A MX2022001601A MX2022001601A MX2022001601A MX 2022001601 A MX2022001601 A MX 2022001601A MX 2022001601 A MX2022001601 A MX 2022001601A MX 2022001601 A MX2022001601 A MX 2022001601A MX 2022001601 A MX2022001601 A MX 2022001601A
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
active ingredient
composition containing
antifungal agent
containing antifungal
Prior art date
Application number
MX2022001601A
Other languages
English (en)
Inventor
Masahiro Ito
Kiyotaka Matsui
Masami Inuma
Original Assignee
Sato Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sato Pharma filed Critical Sato Pharma
Publication of MX2022001601A publication Critical patent/MX2022001601A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención proporciona una técnica que permite que una composición farmacéutica, preferiblemente para uso externo, que contiene luliconazol o similar, contenga luliconazol o similar en una alta concentración, y suprime la precipitación del mismo con el tiempo. La presente invención usa un polietilenglicol que tiene un peso molecular promedio de 380 a 420 representado por una fórmula HOCH2(CH2OCH2)nCH2OH (donde n es un número entero), etanol, alcohol bencílico, ácido láctico, carbonato de propileno y acetona en combinación con el luliconazol o similares.
MX2022001601A 2019-08-13 2020-08-07 Composicion farmaceutica que contiene un agente antifungico como ingrediente activo. MX2022001601A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019148620 2019-08-13
PCT/JP2020/030350 WO2021029350A1 (ja) 2019-08-13 2020-08-07 抗真菌薬を有効成分とする医薬組成物

Publications (1)

Publication Number Publication Date
MX2022001601A true MX2022001601A (es) 2022-03-11

Family

ID=74190800

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022001601A MX2022001601A (es) 2019-08-13 2020-08-07 Composicion farmaceutica que contiene un agente antifungico como ingrediente activo.

Country Status (12)

Country Link
US (2) US10898470B1 (es)
EP (1) EP4015042A4 (es)
JP (1) JP6888180B1 (es)
KR (1) KR20220035954A (es)
CN (1) CN114206387A (es)
AU (1) AU2020327775B2 (es)
BR (1) BR112022002269A2 (es)
CA (1) CA3149802A1 (es)
CL (1) CL2022000330A1 (es)
MX (1) MX2022001601A (es)
NZ (1) NZ785310A (es)
WO (1) WO2021029350A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10898470B1 (en) * 2019-08-13 2021-01-26 Sato Pharmaceutical Co., Ltd. Pharmaceutical composition containing antifungal agent as active ingredient
AU2022297596A1 (en) 2021-06-25 2024-01-04 Schlumberger Technology B.V. Cutting tool and controls for downhole mechanical services
WO2024024520A1 (ja) * 2022-07-28 2024-02-01 花王株式会社 外用剤組成物

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5345937B2 (es) 1974-04-26 1978-12-09
JPS5412723A (en) 1977-06-29 1979-01-30 Bodysonic Kk Attentant feeling reproducing unit
US4162470A (en) 1977-07-26 1979-07-24 Rca Corporation Magnetizing apparatus and method for producing a statically converged cathode ray tube and product thereof
JPS5496659A (en) 1978-01-17 1979-07-31 Nissan Motor Co Ltd Automatic transmission gear
JPS54119654A (en) 1978-03-08 1979-09-17 Daikou Tetsukou Kk Method of producing cylindrical fuse
JPS5938497B2 (ja) 1980-02-25 1984-09-17 日立プラント建設株式会社 風量制御装置
JPH06211651A (ja) 1993-01-12 1994-08-02 Hisamitsu Pharmaceut Co Inc 爪白癬治療用組成物
JP3803393B2 (ja) 1994-01-12 2006-08-02 久光製薬株式会社 爪白癬治療用組成物
AU3673195A (en) 1994-10-13 1996-05-06 Hisamitsu Pharmaceutical Co., Inc. External preparation for nail ringworm
US5900488A (en) 1995-07-08 1999-05-04 Nihon Nohyaku Co., Ltd. Method for treating mycosis using imidazolylacetonitrile derivatives
JP3278738B2 (ja) 1995-07-08 2002-04-30 日本農薬株式会社 抗真菌剤
JP4253047B2 (ja) 1996-09-27 2009-04-08 杏林製薬株式会社 被膜形成性抗真菌剤組成物
US6585963B1 (en) 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
JP5160409B2 (ja) 2006-03-08 2013-03-13 日本農薬株式会社 外用の医薬組成物
MX2008011433A (es) 2006-03-08 2008-09-18 Nihon Nohyaku Co Ltd Composicion farmaceutica para uso externo.
EP2005959B1 (en) 2006-03-08 2015-01-21 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
PL2191828T3 (pl) * 2007-09-05 2017-02-28 Pola Pharma Inc. Przeciwgrzybicza kompozycja farmaceutyczna
CN101808637B (zh) 2007-09-05 2013-07-24 宝丽制药股份有限公司 医药组合物
WO2009031643A1 (ja) 2007-09-05 2009-03-12 Pola Pharma Inc. 抗真菌組成物
CN102395274B (zh) 2009-02-13 2014-03-12 托派卡医药股份有限公司 抗真菌制剂
WO2010117091A2 (en) 2009-04-09 2010-10-14 Pola Pharma Inc. Antimycotic pharmaceutical composition
US10130610B2 (en) 2009-04-09 2018-11-20 Pola Pharma Inc. Antimycotic pharmaceutical composition
KR101754697B1 (ko) 2009-08-25 2017-07-06 가부시키가이샤 폴라 파마 항진균성 약제학적 조성물
US8962669B2 (en) 2010-06-11 2015-02-24 Pola Pharma Inc. Antimycotic pharmaceutical composition
JP5686874B2 (ja) 2012-09-14 2015-03-18 株式会社ポーラファルマ 医薬組成物
JP2014114249A (ja) 2012-12-11 2014-06-26 Kanae Technos:Kk 基剤、及び皮膚外用剤
JP5587488B1 (ja) * 2013-12-12 2014-09-10 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
WO2017216722A2 (en) * 2016-06-13 2017-12-21 Vyome Biosciences Pvt. Ltd. Synergistic antifungal compositions and methods thereof
US10898470B1 (en) * 2019-08-13 2021-01-26 Sato Pharmaceutical Co., Ltd. Pharmaceutical composition containing antifungal agent as active ingredient

Also Published As

Publication number Publication date
JP6888180B1 (ja) 2021-06-16
WO2021029350A1 (ja) 2021-02-18
US10898470B1 (en) 2021-01-26
US11738006B2 (en) 2023-08-29
BR112022002269A2 (pt) 2022-04-19
US20210046052A1 (en) 2021-02-18
AU2020327775A1 (en) 2022-03-10
JPWO2021029350A1 (ja) 2021-09-13
CA3149802A1 (en) 2021-02-18
US20210220338A1 (en) 2021-07-22
AU2020327775B2 (en) 2023-06-08
NZ785310A (en) 2024-05-31
KR20220035954A (ko) 2022-03-22
EP4015042A1 (en) 2022-06-22
CL2022000330A1 (es) 2022-10-21
CN114206387A (zh) 2022-03-18
EP4015042A4 (en) 2023-06-07
TW202114661A (zh) 2021-04-16

Similar Documents

Publication Publication Date Title
MX2022001601A (es) Composicion farmaceutica que contiene un agente antifungico como ingrediente activo.
MX2019013218A (es) Composición oftálmica líquida estable, que comprende una solución acuosa con un tampón, un agente de tonicidad, un quelante, un modificador de la viscosidad y atropina; y el uso de la misma para el tratamiento de la miopía.
CR20230310A (es) Inhibidores de prmt5
CA2492976A1 (en) Solution for ungual and peri-ungual application
NZ708247A (en) Hyaluronic acid based formulations
MX2023009222A (es) Inhibidores tricíclicos-amido-bicíclicos de prmt5.
TR201903499T4 (tr) Bi̇r i̇zoksazoli̇n akti̇f maddesi̇ni̇ i̇çeren parazi̇ti̇si̇dal bi̇leşi̇mler, bunlarin yöntemleri̇ ve kullanimlari
TR201902125T4 (tr) Si̇stemi̇k olarak etki̇ eden akti̇f ajanlari i̇çeren parazi̇ti̇si̇dal oral veteri̇nerli̇ğe ai̇t bi̇leşi̇mler, bunlarin yöntemleri̇ ve kullanimlari
NZ710080A (en) Improved antimicrobial compositions
WO2018201167A3 (en) Propionic acid derivatives and methods of use thereof
CY1122084T1 (el) Συνθεσεις που περιλαμβανουν αμλοδιπινη και μπισοπρολολη
WO2011039444A3 (fr) Composition, utilisation et procédé de conservation
EA202192845A1 (ru) Новые композиции, содержащие мелфлуфен
EA202192322A1 (ru) Фармацевтические составы
HK1108633A1 (en) Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound
MX2022006519A (es) Medicamento conjugado con polietilenglicol, metodo de preparacion del mismo y uso del mismo.
MX2021014680A (es) Derivado de benzotriazol.
PH12020551342A1 (en) Saturated-ring-fused dihydropyrimidinone or dihydrotriazinone compounds and pharmaceutical use thereof
WO2021046315A3 (en) Inhibitors of encephalitic alphaviruses
WO2013080140A3 (en) Sunscreen compositions containing a novel preservative system
WO2019059511A3 (ko) 3,4-디-카페오일퀴닌산을 포함하는, 활성산소종, 자외선 또는 미세먼지에 대한 피부 보호용 화장료 조성물
US20170202766A1 (en) Use of spiculisporic acid and/or a salt thereof as antidandruff agent, and cosmetic treatment process employing same
MX2015008399A (es) Derivado de benzoazepina novedoso y uso medico del mismo.
WO2015100348A8 (en) Keloid reduction using topical allantoin
TR201004754A1 (tr) Yeni Farmasötik Kombinasyonlar